Terheyden JH, Behning C, Lüning A, Wintergerst L, Basile PG, Tavares D, Melício BA, Leal S, Weissgerber G, Luhmann UFO, Crabb DP,Tufail A, Hoyng CB, Berger M, Schmid M, Silva R , Martinho CV, Cunha-Vaz J, Holz FG, Finger RP, MACUSTAR consortium
BMC Med Res Methodol. 2021 Mar 17;21(1):54. doi: 10.1186/s12874-021-01243-8.
2021
Lorenz B, Tavares J, van den Born LI, Marques JP, Scholl HPN, The EVICR.net Group
2021 Mar 8. doi: 10.1159/00051568
2021
Lorenz B, Tavares J, van den Born LI, Marques JP, Scholl HPN.
Ophthalmic Res. 2021 Jan 19. doi: 10.1159/000514540
2021
Development of a Genotype Assay for Age-Related Macular Degeneration: The EYE-RISK Consortium
de Breuk A, Acar IE, Kersten E, Schijvenaars MMVAP, Colijn JM, Haer-Wigman L, Bakker B, de Jong S, Meester-Smoor MA, Timo Verzijden, Missotten TOAR, Monés J, Biarnés M, Pauleikhoff D, Hense HW, Silva R, Nunes S, Melo JB, Fauser S, Hoyng CB, Ueffing M, Coenen MJH, Klaver CCW, den Hollander AI, EYE-RISK Consortium.
Ophthalmology. 2020 Jul 24;S0161-6420(20)30725-9. doi: 10.1016/j.ophtha.2020.07.037.
Use of composite endpoints in early and intermediate age-related macular degeneration clinical trials – state-of-the-art and future directions
Terheyden J.H. Schmitz-Valckenberg S. Crabb D. Dunbar H. Luhmann U. Behning C. Schmid M. Pires I. Cunha-Vaz J. Tufail A. Weissgerber G. Leal S. Holz F.G. Finger R.P.
Ophthalmologica. 2020 Dec 7. doi: 10.1159/000513591.
https://www.karger.com/Article/Abstract/513591
Phenotypic And Genetic Variations Between Asian And Caucasian Polypoidal Choroidal Vasculopathy Eyes.
Jordan-Yu, JMN, Teo K, Fan Q, Gan JC, Leopoldo AK, Nunes S, Farinha C. Barreto P, Melo JB, Carreira I, Murta JN, Silva R, Cheung CMG
Br. J. Ophthalmol. 317537, (2020). doi: 10.1136/bjophthalmol-2020-317537
https://bjo.bmj.com/content/early/2020/10/13/bjophthalmol-2020-317537.long#
Clinical study protocol for a low-interventional study in intermediate age-related macular degeneration developing novel clinical endpoints for interventional clinical trials with a regulatory and patient access intention-MACUSTAR.
Jan H Terheyden , Frank G Holz , Steffen Schmitz-Valckenberg , Anna Lüning , Matthias Schmid , Gary S Rubin, Hannah Dunbar, Adnan Tufail , David P Crabb, Alison Binns , Clara I Sánchez, Carel Hoyng 6, Philippe Margaron, Nadia Zakaria, Mary Durbin, Ulrich Luhmann , Parisa Zamiri , José Cunha-Vaz, Cecília Martinho, Sergio Leal , Robert P Finger , MACUSTAR consortium
Trials . 2020 Jul 18;21(1):659. doi: 10.1186/s13063-020-04595-6.
2020
Safety Assessment of an A‐Scan Ultrasonic System for Ophthalmic Use.
Petrella L.; Fernandes P; Santos M; Caixinha M.; Nunes S.; Pinto C.; Morgado M.; Santos J.; Perdigão F.; Gomes M.
J Ultrasound Med 2020; 9999:1–8 doi:10.1002/jum.15323
2020
Characterization of disease progression in the initial stages of retinopathy in diabetes type 2. A two-year longitudinal study.
Inês P. Marques, Dalila Alves, Torcato Santos, Luís Mendes, Conceição Lobo, Ana Rita Santos, Mary Durbin, José Cunha-Vaz
Invest Ophthalmol Vis Sci. 2020 Mar 9;61(3):20. doi: 10.1167/iovs.61.3.20.
2020
Unmet Medical Needs in Ophthalmic Research: An EVI Consensus Roadmap. 2019-2025. Diabetic Retinopathy
Cunha-Vaz J
Ophthalmic Res. 2019;62(3):123-133. doi: 10.1159/000501374. Epub 2019 Aug 5.
2019
